177Lu-PSMA-EB-01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 177Lu-PSMA-EB-01, covering 2024-07-10 to 2024-07-10. Get the full timeline:
Most recent: Clinical Trial Update: 177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate Cancer [NA]